Boston Scientific BSX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $850M-11.9% | $965M+8.1% | $893M+130% | $388M+12.5% | $345M-5.2% | ||
| $3.15B+3.1% | $3.06B+3.3% | $2.96B+1.2% | $2.93B+4.3% | $2.81B+5.2% | ||
| $3.12B+5.9% | $2.94B+0.8% | $2.92B+2.1% | $2.86B-0.2% | $2.87B+2.0% | ||
| $8.68B-1.3% | $8.79B+9.4% | $8.04B+12.8% | $7.12B-2.9% | $7.34B+6.0% | ||
| $4.06B+0.7% | $4.04B+6.4% | $3.8B+9.7% | $3.46B+2.1% | $3.39B+2.9% | ||
| $18.54B+1.4% | $18.28B+0.4% | $18.21B+0.8% | $18.08B+4.2% | $17.34B+1.5% | ||
| $44.35B+1.6% | $43.67B+2.3% | $42.71B+2.8% | $41.56B+3.5% | $40.14B+1.9% | ||
| $1.14B-0.3% | $1.14B+14.2% | $1B+4.2% | $962M-4.2% | $1B+4.6% | ||
| $4.57B-16.0% | $5.44B+2.1% | $5.33B+2.7% | $5.19B+2.6% | $5.06B-21.0% | ||
| —— | —— | —— | —— | —— | ||
| $6.91B+24.1% | $5.57B+13.7% | $4.9B+18.2% | $4.14B+23.8% | $3.35B+25.2% | ||
| $25.86B+6.7% | $24.23B+3.6% | $23.39B+4.4% | $22.42B+0.9% | $22.21B+2.0% | ||
| $44.35B+1.6% | $43.67B+2.3% | $42.71B+2.8% | $41.56B+3.5% | $40.14B+1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's total assets?
- Boston Scientific (BSX) holds $44.4B in total assets, up 10.5% year over year.
- How much cash does Boston Scientific have?
- Boston Scientific holds $850.0M in cash and equivalents.
- Can Boston Scientific cover its short-term obligations?
- Its current ratio is 1.90 — current assets exceed current liabilities.
- Where does Boston Scientific's balance sheet data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
